The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - The Jackson Laboratory
Consulting or Advisory Role - AlphaSights; Bayer; The Jackson Laboratory
Phase 2 study of larotrectinib in children with newly diagnosed infantile fibrosarcoma (IFS): Children’s Oncology Group (COG) ADVL1823 cohort A.
 
Theodore Willis Laetsch
Stock and Other Ownership Interests - Advanced Microbubbles
Consulting or Advisory Role - AI Therapeutics; Aptitude Health; Bayer; GentiBio; Jazz Pharmaceuticals; Jumo Health; Massive Bio; Medscape; Menarini; Novartis; Pyramid Biosciences; Targeted Oncology; Treeline Biosciences
Research Funding - Advanced Accelerator Applications/Novartis; Bayer (Inst); BioAtla; Bristol-Myers Squibb; Lilly; Pfizer (Inst); Roche; Roche/Genentech; Taiho Oncology; Turning Point Therapeutics (Inst)
 
Kathleen Ludwig
No Relationships to Disclose
 
David Hall
No Relationships to Disclose
 
Donald A. Barkauskas
Employment - Genentech (I)
Patents, Royalties, Other Intellectual Property - U.S. patent based on Ph.D. research in glioblastoma (I)
 
Stephan D. Voss
No Relationships to Disclose
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Joan Ronan
No Relationships to Disclose
 
Erin R. Rudzinski
No Relationships to Disclose
 
Amanda Memken
No Relationships to Disclose
 
Krystal Robinson
No Relationships to Disclose
 
Joel Sorger
No Relationships to Disclose
 
Joel M. Reid
Consulting or Advisory Role - Elucida Oncology
 
Teena Bhatla
No Relationships to Disclose
 
Brian D. Crompton
Employment - Acceleron Pharma (I); Generate Biomedicines (I)
Stock and Other Ownership Interests - Acceleron Pharma (I)
Consulting or Advisory Role - Animal Cancer Foundation; AstraZeneca; PetDx
Research Funding - Gradalis
 
Alanna J. Church
No Relationships to Disclose
 
Elizabeth Fox
No Relationships to Disclose
 
Brenda Weigel
No Relationships to Disclose